Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine
Nexcelom from PerkinElmer

Where: C3/C4
Founded in 2003, Nexcelom Bioscience focuses on providing laboratory solutions to meet and exceed the specific wants and needs of today’s researchers. We collaborate with customers every day, analyzing new cell types, validating new cell-based assays, and exploring new therapeutic areas and methodologies. Through joint application development, we learn from our customers, the experts in their fields, and assist with integration into their current workflows. Products range from cell viability counters to high-throughput automated image cytometry workstations for cell quantification, analysis, and cell-based assays, used globally in academic and government research institutes, biotechnology, and industrial settings. Cellometer®, Cellaca™ MX, and Celigo® image cytometry products have been widely used in new drug development, immunotherapy, vaccine development, drug evaluation, brewery, and bioenergy process development. Nexcelom's solutions automate time-consuming procedures, enabling scientists to focus less on the process and more on the research results.
Tel: 617-320-1438
Address: 360 Merrimack Street
Lawrence, MA
Website: http://www.nexcelom.com
Email: sales@nexcelom.co.uk

Presentations at Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine

Staff Attending

Dr Kris Coupland
Nexcelom Bioscience Ltd
Dr Scott Cribbes
EMEAI Business Development Director
Nexcelom Bioscience Ltd
Mr Scott Cribbes
Director, Bus Develop Emeai
Nexcelom Bioscience Ltd
United States
Ms Paula Dickinson
EMEAi Office Operations Manager
Nexcelom Bioscience Ltd
United States
Mrs Anam Riaz
Service and support specialist
Nexcelom Bioscience UK
Dr Daniel Tome
Territory Sales Manager Mainland UK
Nexcelom Bioscience Ltd

Find out more...